Brief: Pixium Vision Gets FDA Approval For Human Clinical Study Of Prima Sub-Retinal Implant

Pixium Vision SA

04/01/2018 06:01

Jan 4 (Reuters) - PIXIUM VISION SA  PIX.PA : 
    * PIXIUM VISION RECEIVES FDA APPROVAL TO BEGIN HUMAN 
CLINICAL 
STUDY OF ITS PRIMA SUB-RETINAL IMPLANT IN THE US 
    * RECEIVES FDA APPROVAL TO BEGIN HUMAN CLINICAL STUDY OF ITS 
PRIMA 
SUB-RETINAL IMPLANT IN US 
    * FEASIBILITY CLINICAL STUDY IS DESIGNED TO EVALUATE PRIMA 
IN 
PATIENTS WITH ATROPHIC DRY AGE-RELATED MACULAR DEGENERATION 
    * EXPECTS TO START US STUDY IN FIRST HALF OF 2018. 
 
Source text for Eikon:  ID:nBw97r5YGa  
Further company coverage:  PIX.PA  
 
 (Gdynia Newsroom:) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))